VisasQ Inc. (TYO:4490)
Japan · Delayed Price · Currency is JPY 766.00
+14.00 (1.86%)
Aug 4, 2025, 3:30 PM JST
Verve Therapeutics Revenue
VisasQ had revenue of 2.45B JPY in the quarter ending May 31, 2025, a decrease of -2.94%. This brings the company's revenue in the last twelve months to 9.71B, up 3.77% year-over-year. In the fiscal year ending February 28, 2025, VisasQ had annual revenue of 9.78B with 9.07% growth.
Revenue (ttm)
9.71B
Revenue Growth
+3.77%
P/S Ratio
0.72
Revenue / Employee
19.53M
Employees
497
Market Cap
6.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 9.78B | 813.00M | 9.07% |
| Feb 29, 2024 | 8.97B | 587.00M | 7.00% |
| Feb 28, 2023 | 8.38B | 4.68B | 126.36% |
| Feb 28, 2022 | 3.70B | 2.10B | 130.80% |
| Feb 28, 2021 | 1.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hitachi | 9,830.27B |
| Recruit Holdings | 3,557.48B |
| Mitsubishi Heavy Industries | 5,027.18B |
| Mitsubishi | 18.62T |
| ITOCHU | 14.68T |
| Mitsui & | 14.12T |
| Mitsubishi Electric | 5,548.12B |
| Daikin Industries,Ltd. | 4,752.34B |